-
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
24 Apr 2024 11:47 GMT
… is a Canadian clinical stage drug development company investigating multiple drugs for unmet … privately owned U.S. based drug development company, for the acquisition of Algernon …
-
End Brain Cancer Initiative Looking to Partner with GBM Drug Development Companies to Help Fight for Patient Access
25 Mar 2024 17:02 GMT
… Initiative (EBCI) engages directly with drug development companies to insert the patient voice … on-site to meet with drug development companies that want to partner with …
-
Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada
23 Apr 2024 13:05 GMT
… , Inc. is transitioning from a drug development company committed to commercializing its proprietary …
-
FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says
12 Feb 2024 20:21 GMT
… , according to the psychedelics-focused drug development company that’s leading the effort …
-
Best of the week — the five most popular stories among readers, April 15 – 19, 2024
21 Apr 2024 20:48 GMT
… manufacture mRNA vaccines under development
Drug development company IDT Australia and pharmaceutical business …
-
Histogen Files For Voluntary Chapter 11 Bankruptcy Protection
19 Apr 2024 03:43 GMT
Histogen Inc. (HSTO), a drug development company for treatment of bacterial skin …
-
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
18 Apr 2024 21:29 GMT
… , the “Company” or “Histogen”), a drug development company for treatment of bacterial skin …
-
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
18 Apr 2024 12:30 GMT
… . (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral …
-
'Innovation and technology': Oncology drug development company using AI relocates to Pittsburgh
22 Jul 2023 10:04 GMT
-
Xeno Biosciences Announces New CEO and Financing
17 Apr 2024 17:41 GMT
… Inc. is a privately held drug development company dedicated to finding safe and …